Co-Authors
This is a "connection" page, showing publications co-authored by Kathryn Lancaster and David Kline.
Connection Strength
1.214
-
Kline DM, White BN, Lancaster KE, Egan KL, Murphy E, Miller WC, Hepler SA. Estimating prevalence of opioid misuse in North Carolina counties from 2016-2021: An integrated abundance model approach. Epidemiology. 2025 Jan 24.
Score: 0.249
-
Estadt AT, Kline D, Miller WC, Feinberg J, Hurt CB, Mixson LS, Friedmann PD, Lowe K, Tsui JI, Young AM, Cooper H, Korthuis PT, Pho MT, Jenkins W, Westergaard RP, Go VF, Brook D, Smith G, Rice DR, Lancaster KE. Differences in hepatitis C virus (HCV) testing and treatment by opioid, stimulant, and polysubstance use among people who use drugs in rural U.S. communities. Harm Reduct J. 2024 Nov 29; 21(1):214.
Score: 0.246
-
Estadt AT, White BN, Ricks JM, Lancaster KE, Hepler S, Miller WC, Kline D. The impact of fentanyl on state- and county-level psychostimulant and cocaine overdose death rates by race in Ohio from 2010 to 2020: a time series and spatiotemporal analysis. Harm Reduct J. 2024 Jan 17; 21(1):13.
Score: 0.234
-
Estadt AT, Miller WC, Kline D, Whitney BM, Young AM, Todd Korthuis P, Stopka TJ, Feinberg J, Zule WA, Pho MT, Friedmann PD, Westergaard RP, Eagen KV, Seaman A, Ma J, Go VF, Lancaster KE. Associations of hepatitis C virus (HCV) antibody positivity with opioid, stimulant, and polysubstance injection among people who inject drugs (PWID) in rural U.S. communities. Int J Drug Policy. 2023 Oct 06; 104222.
Score: 0.229
-
Brook DL, Hetrick AT, Chettri SR, Schalkoff CA, Sibley AL, Lancaster KE, Go VF, Miller WC, Kline DM. The Relationship Between Hepatitis C Virus Rates and Office-Based Buprenorphine Access in Ohio. Open Forum Infect Dis. 2021 Jun; 8(6):ofab242.
Score: 0.194
-
Murphy E, Kline D, Egan KL, Lancaster KE, Miller WC, Waller LA, Hepler SA. Understanding the opioid syndemic in North Carolina: A novel approach to modeling and identifying factors. Biostatistics. 2024 Dec 31; 26(1).
Score: 0.062